Reporte zur Charge UO29322

Symptomtext

No additional AE; Medical assistant reported that a patient received additional VARIVAX.; This spontaneous report was received from a medical assistant, referring to a patient of unknown age or gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported. On an unknown date, the patient was properly vaccinated with measles, mumps, and rubella (WISTAR RA 27-3) virus vaccine, live (MMR II) (strength, dose, route of administration, lot # and expired date were not provided) and varicella virus vaccine live (OKA/MERCK) (VARIVAX) (strength, dose, route of administration, lot # and expired date were not provided); however on 26-APR-2022, the patient received another dose of varicella virus vaccine live (OKA/MERCK) (VARIVAX) (Extra dose administered) (valid lot #U026207, expiration date: 24-AUG-2023) for prophylaxis (strength and route of administration were not provided) which was reconstituted with a sterile diluent (valid lot #T015779, expiration date: 02-DEC-2022). No additional adverse events were reported, no further information was provided.